Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down 0.08% Nasdaq Down 0.83%
Streaming
Ticker Tape: On

Nektar Therapeutics (NKTR)

-NasdaqGS
11.96 0.30(2.45%) Apr 23, 4:00PM EDT
Get the big picture on all your investments.
Prev Close:12.26
Open:12.24
Bid:9.50 x 100
Ask:12.44 x 400
1y Target Est:15.57
Beta:1.53
Earnings Date:May 5 - May 9 (Est.)
Day's Range:11.76 - 12.35
52wk Range:8.72 - 15.34
Volume:1,013,703
Avg Vol (3m):1,365,040
Market Cap:1.51B
P/E (ttm):N/A
EPS (ttm):-1.40
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
NKTRDown 2.45%1.51B
BMY84.08B
ENZN45.86M
GSK132.09B

Key Statistics

Forward P/E (1 yr):199.33
P/S (ttm):10.43
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.62
Quarterly EPS Est (Mar-14) :-0.04
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):-0.97

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Nektar Therapeutics, a clinical-stage biopharmaceutical company, develops drug candidates that utilize its PEGylation and polymer conjugate technology platforms in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback